loteprednol
Selected indexed studies
- Loteprednol. (, 2006) [PMID:29999696]
- Loteprednol Etabonate for the Treatment of Dry Eye Disease. (J Ocul Pharmacol Ther, 2020) [PMID:32391735]
- Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery. (Clin Drug Investig, 2020) [PMID:32172521]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Efficacy and safety of loteprednol etabonate versus fluorometholone in the treatment of patients after corneal refractive surgery: a meta-analysis. (2023) pubmed
- Loteprednol. (2006) pubmed
- Loteprednol Etabonate for the Treatment of Dry Eye Disease. (2020) pubmed
- Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery. (2020) pubmed
- Review of Loteprednol Etabonate 0.5%/Tobramycin 0.3% in the Treatment of Blepharokeratoconjunctivitis. (2021) pubmed
- Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid. (2018) pubmed
- Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use. (2012) pubmed
- Loteprednol etabonate in the treatment of allergic conjunctivitis: a meta-analysis. (2015) pubmed
- Efficacy and Safety of Nanoparticle Loteprednol Etabonate Compared to Vehicle in Post-cataract Surgery Pain and Anterior Chamber Inflammation Management: A Systematic Review and Meta-Analysis. (2024) pubmed
- Loteprednol etabonate: a review of ophthalmic clinical studies. (2000) pubmed